speb/financial-data huggingface dataset:
CBAT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 34776759.00
CBAT balance_sheet (quarterly, 2025-09-30) — Finished Goods: 18420960.00
CBAT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 5998355.00
CBAT cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: 0.00
CBAT cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 44143.00
CBAT income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 0.00
CBAT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -8702415.00
CBAT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 3872549.00
CBAT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 12289876.00
CBAT balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 26961393.00
CBAT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 238334881.00
CBAT income_statement (quarterly, 2025-09-30) — Gross Profit: 4875723.00
CBAT cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
CBAT cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 312624.00
CBAT balance_sheet (quarterly, 2025-09-30) — Interest Payable: 75858.00
CBAT balance_sheet (quarterly, 2025-09-30) — Inventory: 34487742.00
CBAT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 156076394.00
CBAT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -8440371.00
CBAT balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 16898724.00
CBAT balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 18599596.00
CBAT cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 15097111.00
CBAT balance_sheet (quarterly, 2025-09-30) — Leases: 9482889.00
CBAT balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 29569757.00
CBAT balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1980733.00
CBAT balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 4760768.00
CBAT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 6741501.00
CBAT cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 15097111.00
CBAT cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -19820864.00
CBAT balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 1700872.00
CBAT balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 473224.00
CBAT balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 90661743.00
CBAT balance_sheet (quarterly, 2025-09-30) — Minority Interest: -2952963.00
CBAT income_statement (quarterly, 2025-09-30) — Minority Interests: 567955.00
CBAT cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CBAT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -263111.00
CBAT balance_sheet (quarterly, 2025-09-30) — Net Debt: 24190883.00
CBAT income_statement (quarterly, 2025-09-30) — Net Income: 2650503.00
CBAT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2650503.00
CBAT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2082548.00
CBAT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2650503.00
CBAT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2650503.00
CBAT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2082548.00
CBAT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2082548.00
CBAT income_statement (quarterly, 2025-09-30) — Net Interest Income: -219768.00
CBAT cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
CBAT cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -4723753.00
CBAT cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -4723753.00
CBAT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -219768.00
CBAT cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 39763623.00
CBAT cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 12231.00
CBAT balance_sheet (quarterly, 2025-09-30) — Net PPE: 175280182.00
CBAT cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -8452602.00
CBAT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 109119381.00
CBAT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 10189350.00
CBAT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 10189350.00
CBAT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2499592.00
CBAT income_statement (quarterly, 2025-09-30) — Normalized Income: 2650503.00
CBAT balance_sheet (quarterly, 2025-09-30) — Notes Receivable: 23369064.00
CBAT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 14599484.00
CBAT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 43996.00
CBAT income_statement (quarterly, 2025-09-30) — Operating Income: -4033673.00
CBAT income_statement (quarterly, 2025-09-30) — Operating Revenue: 60923560.00
CBAT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 88645836.00
CBAT balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 336612.00
CBAT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -8702415.00
CBAT balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 7955358.00
CBAT income_statement (quarterly, 2025-09-30) — Other Gand A: 3872549.00
CBAT income_statement (quarterly, 2025-09-30) — Other Income Expense: 6152136.00
CBAT balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 12289876.00
CBAT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 6151989.00
CBAT balance_sheet (quarterly, 2025-09-30) — Other Payable: 115857862.00
CBAT balance_sheet (quarterly, 2025-09-30) — Other Properties: 2983055.00
CBAT balance_sheet (quarterly, 2025-09-30) — Other Receivables: 3937073.00
CBAT balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 0.00
CBAT balance_sheet (quarterly, 2025-09-30) — Payables: 167114036.00
CBAT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 177397468.00
CBAT balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 2770786.00
CBAT income_statement (quarterly, 2025-09-30) — Pretax Income: 1898695.00
CBAT balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CBAT income_statement (quarterly, 2025-09-30) — Provision For Doubtful Accounts: -157510.00
CBAT cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -157510.00
CBAT cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
CBAT cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -8601129.00
CBAT balance_sheet (quarterly, 2025-09-30) — Raw Materials: 7009348.00
CBAT balance_sheet (quarterly, 2025-09-30) — Receivables: 57086211.00
CBAT balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -225121.00
CBAT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 56047837.00
CBAT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1534081.00
CBAT cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -19820864.00
CBAT cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -263111.00
CBAT income_statement (quarterly, 2025-09-30) — Research And Development: 3861633.00
CBAT balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 52872417.00
CBAT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -126419516.00
CBAT cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
CBAT cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 148527.00
CBAT income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1332724.00
CBAT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5205273.00
CBAT balance_sheet (quarterly, 2025-09-30) — Share Issued: 88645836.00
CBAT income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CBAT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 13923.00
CBAT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 121409257.00
CBAT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 109119381.00
CBAT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CBAT income_statement (quarterly, 2025-09-30) — Tax Provision: -183853.00
CBAT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
CBAT balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 5500546.00
CBAT balance_sheet (quarterly, 2025-09-30) — Total Assets: 363863064.00
CBAT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 126170025.00
CBAT balance_sheet (quarterly, 2025-09-30) — Total Debt: 37995673.00
CBAT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 118456294.00
CBAT income_statement (quarterly, 2025-09-30) — Total Expenses: 64957233.00
CBAT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 245406770.00
CBAT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 206169654.00
CBAT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 17404075.00
CBAT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -4033673.00
CBAT income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 219768.00
CBAT balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1065402.00
CBAT income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
CBAT income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CBAT balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 0.00
CBAT balance_sheet (quarterly, 2025-09-30) — Work In Process: 9057434.00
CBAT balance_sheet (quarterly, 2025-09-30) — Working Capital: -70309285.00
CBAT income_statement (annual, 2025-12-31) — +Operating Expense: 37074008.00
CBAT income_statement (quarterly, 2025-12-31) — +Operating Expense: 12507874.00
CBAT income_statement (annual, 2025-12-31) — +Total Revenue: 195189306.00
CBAT income_statement (quarterly, 2025-12-31) — +Total Revenue: 58802512.00
CBAT balance_sheet (annual, 2025-12-31) — Accounts Payable: 60046427.00
CBAT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 60046427.00
CBAT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 27822345.00
CBAT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 27822345.00
CBAT balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 124101.00
CBAT balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 124101.00
CBAT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -67210443.00
CBAT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -67210443.00
CBAT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 248500176.00
CBAT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 248500176.00
CBAT balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1062148.00
CBAT balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1062148.00
CBAT cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 6607039.00
CBAT cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 2859752.00
CBAT balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 17148704.00
CBAT balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 17148704.00
CBAT income_statement (annual, 2025-12-31) — Basic Average Shares: 89247119.00
CBAT income_statement (annual, 2025-12-31) — Basic EPS: -0.10
CBAT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 60786002.00
CBAT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 63348671.00
CBAT balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 89341079.00
CBAT balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 89341079.00
CBAT cash_flow (annual, 2025-12-31) — Capital Expenditure: -45752180.00
CBAT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -13742220.00
CBAT balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 4748401.00
CBAT balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 4748401.00
CBAT balance_sheet (annual, 2025-12-31) — Capital Stock: 88646.00
CBAT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 88646.00
CBAT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8301149.00
CBAT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8301149.00
CBAT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8301149.00
CBAT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8301149.00
CBAT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 8004496.00
CBAT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2198156.00
CBAT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -45714729.00
CBAT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -16660287.00
CBAT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 48554479.00
CBAT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 29807631.00
CBAT cash_flow (annual, 2025-12-31) — Change In Account Payable: 63655464.00
CBAT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 32508121.00
CBAT cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 11055969.00
CBAT cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 8557318.00
CBAT cash_flow (annual, 2025-12-31) — Change In Inventory: -33886698.00
CBAT cash_flow (quarterly, 2025-12-31) — Change In Inventory: -18305319.00
CBAT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 197097.00
CBAT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 1114170.00
CBAT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 8305.00
CBAT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -2262.00
CBAT cash_flow (annual, 2025-12-31) — Change In Payable: 63655464.00
CBAT cash_flow (quarterly, 2025-12-31) — Change In Payable: 32691972.00
CBAT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 74711433.00
CBAT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 41249290.00
CBAT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 5402245.00
CBAT cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -3514465.00
CBAT cash_flow (annual, 2025-12-31) — Change In Receivables: -4083836.00
CBAT cash_flow (quarterly, 2025-12-31) — Change In Receivables: 9685274.00
CBAT cash_flow (annual, 2025-12-31) — Change In Working Capital: 42348546.00
CBAT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 30226688.00
CBAT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -3899151.00
CBAT cash_flow (annual, 2025-12-31) — Changes In Cash: 10844246.00
CBAT cash_flow (quarterly, 2025-12-31) — Changes In Cash: 10949188.00
CBAT balance_sheet (annual, 2025-12-31) — Common Stock: 88646.00
CBAT balance_sheet (quarterly, 2025-12-31) — Common Stock: 88646.00
CBAT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 112678073.00
CBAT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 112678073.00
CBAT cash_flow (annual, 2025-12-31) — Common Stock Payments: -1500231.00
CBAT cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
CBAT balance_sheet (annual, 2025-12-31) — Construction In Progress: 32046421.00
CBAT balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 32046421.00
CBAT income_statement (annual, 2025-12-31) — Cost Of Revenue: 176766718.00
CBAT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 54519790.00
CBAT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 13087354.00
CBAT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 13087354.00
CBAT balance_sheet (annual, 2025-12-31) — Current Assets: 180638711.00
CBAT balance_sheet (quarterly, 2025-12-31) — Current Assets: 180638711.00
CBAT balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 2654973.00
CBAT balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 2654973.00
CBAT balance_sheet (annual, 2025-12-31) — Current Debt: 28870094.00
CBAT balance_sheet (quarterly, 2025-12-31) — Current Debt: 28870094.00
CBAT balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 31525067.00
CBAT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 31525067.00
CBAT balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 29237168.00
CBAT balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 29237168.00
CBAT balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 29237168.00
CBAT balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 29237168.00
CBAT balance_sheet (annual, 2025-12-31) — Current Liabilities: 299848008.00
CBAT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 299848008.00
CBAT balance_sheet (annual, 2025-12-31) — Current Provisions: 339136.00
CBAT balance_sheet (quarterly, 2025-12-31) — Current Provisions: 339136.00
CBAT cash_flow (annual, 2025-12-31) — Depreciation: 10575797.00
CBAT cash_flow (quarterly, 2025-12-31) — Depreciation: 4332374.00
CBAT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 10575797.00
CBAT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 4332374.00
CBAT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 10575797.00
CBAT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 4332374.00
CBAT income_statement (annual, 2025-12-31) — Diluted Average Shares: 89247119.00
CBAT income_statement (annual, 2025-12-31) — Diluted EPS: -0.10
CBAT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -9378119.00
CBAT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -7376424.00
CBAT balance_sheet (annual, 2025-12-31) — Dividends Payable: 1271109.00
CBAT balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 1271109.00
CBAT income_statement (annual, 2025-12-31) — EBIT: -18651420.00
CBAT income_statement (quarterly, 2025-12-31) — EBIT: -8225152.00
CBAT income_statement (annual, 2025-12-31) — EBITDA: -8075623.00
CBAT income_statement (quarterly, 2025-12-31) — EBITDA: -3892778.00
CBAT income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 145097.00
CBAT income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 111295.00
CBAT cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -145097.00
CBAT cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -111295.00
CBAT cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 4047014.00
CBAT cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 1379403.00
CBAT cash_flow (annual, 2025-12-31) — End Cash Position: 75677262.00
CBAT cash_flow (quarterly, 2025-12-31) — End Cash Position: 75677262.00
CBAT cash_flow (annual, 2025-12-31) — Financing Cash Flow: 8004496.00
CBAT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2198156.00
CBAT balance_sheet (annual, 2025-12-31) — Finished Goods: 26648940.00
CBAT balance_sheet (quarterly, 2025-12-31) — Finished Goods: 26648940.00
CBAT cash_flow (annual, 2025-12-31) — Free Cash Flow: 2802299.00
CBAT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 16065411.00
CBAT cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 200068.00
CBAT cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
CBAT cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
CBAT cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 53434.00
CBAT cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -19702.00
CBAT income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 0.00
CBAT income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 0.00
CBAT income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -440054.00
CBAT balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -10070167.00
CBAT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -10070167.00
CBAT income_statement (annual, 2025-12-31) — General And Administrative Expense: 16195504.00
CBAT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5167959.00
CBAT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 12380518.00
CBAT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 12380518.00
CBAT balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 28884493.00
CBAT balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 28884493.00
CBAT balance_sheet (annual, 2025-12-31) — Gross PPE: 281384256.00
CBAT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 281384256.00
CBAT income_statement (annual, 2025-12-31) — Gross Profit: 18422588.00
CBAT income_statement (quarterly, 2025-12-31) — Gross Profit: 4282722.00
CBAT income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
CBAT cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
CBAT cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
CBAT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 871632.00
CBAT cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 217632.00
CBAT balance_sheet (annual, 2025-12-31) — Interest Payable: 82157.00
CBAT balance_sheet (quarterly, 2025-12-31) — Interest Payable: 82157.00
CBAT balance_sheet (annual, 2025-12-31) — Inventory: 50602287.00
CBAT balance_sheet (quarterly, 2025-12-31) — Inventory: 50602287.00
CBAT balance_sheet (annual, 2025-12-31) — Invested Capital: 145666795.00
CBAT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 145666795.00
CBAT cash_flow (annual, 2025-12-31) — Investing Cash Flow: -45714729.00
CBAT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -16660287.00
CBAT balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 17148704.00
CBAT balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 17148704.00
CBAT balance_sheet (annual, 2025-12-31) — Investments And Advances: 18988594.00
CBAT balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 18988594.00
CBAT cash_flow (annual, 2025-12-31) — Issuance Of Debt: 51177399.00
CBAT cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 5342556.00
CBAT balance_sheet (annual, 2025-12-31) — Leases: 8790749.00
CBAT balance_sheet (quarterly, 2025-12-31) — Leases: 8790749.00
CBAT balance_sheet (annual, 2025-12-31) — Line Of Credit: 28532938.00
CBAT balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 28532938.00
CBAT balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2093428.00
CBAT balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2093428.00
CBAT balance_sheet (annual, 2025-12-31) — Long Term Debt: 4118628.00
CBAT balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 4118628.00
CBAT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6212056.00
CBAT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6212056.00
CBAT cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
CBAT cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -45834843.00
CBAT cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -116857.00
CBAT cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 38414796.00
CBAT balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 1839890.00
CBAT balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 1839890.00
CBAT balance_sheet (annual, 2025-12-31) — Long Term Provisions: 446553.00
CBAT balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 446553.00
CBAT balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 148137416.00
CBAT balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 148137416.00
CBAT balance_sheet (annual, 2025-12-31) — Minority Interest: -3198482.00
CBAT balance_sheet (quarterly, 2025-12-31) — Minority Interest: -3198482.00
CBAT income_statement (annual, 2025-12-31) — Minority Interests: 1573816.00
CBAT income_statement (quarterly, 2025-12-31) — Minority Interests: 246679.00
CBAT cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -2931471.00
CBAT cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -2931471.00
CBAT cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -1500231.00
CBAT cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CBAT balance_sheet (annual, 2025-12-31) — Net Debt: 24687573.00
CBAT balance_sheet (quarterly, 2025-12-31) — Net Debt: 24687573.00
CBAT income_statement (annual, 2025-12-31) — Net Income: -9378119.00
CBAT income_statement (quarterly, 2025-12-31) — Net Income: -7376424.00
CBAT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -9378119.00
CBAT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -7376424.00
CBAT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -10951935.00
CBAT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -7623103.00
CBAT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9378119.00
CBAT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -7376424.00
CBAT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9378119.00
CBAT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -7376424.00
CBAT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -10951935.00
CBAT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -7623103.00
CBAT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -10951935.00
CBAT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -7623103.00
CBAT income_statement (annual, 2025-12-31) — Net Interest Income: -673344.00
CBAT income_statement (quarterly, 2025-12-31) — Net Interest Income: -335393.00
CBAT cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CBAT cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CBAT cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 5265608.00
CBAT cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -2037582.00
CBAT cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -116857.00
CBAT cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -7420047.00
CBAT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -673344.00
CBAT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -335393.00
CBAT cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 4239119.00
CBAT cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -160574.00
CBAT cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 2819721.00
CBAT cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 12730.00
CBAT balance_sheet (annual, 2025-12-31) — Net PPE: 214173813.00
CBAT balance_sheet (quarterly, 2025-12-31) — Net PPE: 214173813.00
CBAT cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -45602979.00
CBAT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -13741546.00
CBAT cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 5382465.00
CBAT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 100297555.00
CBAT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 100297555.00
CBAT balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 10195428.00
CBAT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 10195428.00
CBAT balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 10195428.00
CBAT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 10195428.00
CBAT income_statement (annual, 2025-12-31) — Normalized EBITDA: -7845746.00
CBAT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -3662901.00
CBAT income_statement (annual, 2025-12-31) — Normalized Income: -9152054.20
CBAT income_statement (quarterly, 2025-12-31) — Normalized Income: -7146572.12
CBAT balance_sheet (annual, 2025-12-31) — Notes Receivable: 10583053.00
CBAT balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 10583053.00
CBAT cash_flow (annual, 2025-12-31) — Operating Cash Flow: 48554479.00
CBAT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 29807631.00
CBAT cash_flow (annual, 2025-12-31) — Operating Gains Losses: 108405.00
CBAT cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 69071.00
CBAT income_statement (annual, 2025-12-31) — Operating Income: -18651420.00
CBAT income_statement (quarterly, 2025-12-31) — Operating Income: -8225152.00
CBAT income_statement (annual, 2025-12-31) — Operating Revenue: 195189306.00
CBAT income_statement (quarterly, 2025-12-31) — Operating Revenue: 58802512.00
CBAT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 88645836.00
CBAT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 88645836.00
CBAT balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 337156.00
CBAT balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 337156.00
CBAT balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 728423.00
CBAT balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 728423.00
CBAT balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -10070167.00
CBAT balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -10070167.00
CBAT balance_sheet (annual, 2025-12-31) — Other Equity Interest: 7955358.00
CBAT balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 7955358.00
CBAT income_statement (annual, 2025-12-31) — Other Gand A: 16195504.00
CBAT income_statement (quarterly, 2025-12-31) — Other Gand A: 5167959.00
CBAT income_statement (annual, 2025-12-31) — Other Income Expense: 8188143.00
CBAT income_statement (quarterly, 2025-12-31) — Other Income Expense: 936609.00
CBAT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 12380518.00
CBAT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 12380518.00
CBAT income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 8272923.00
CBAT income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1055191.00
CBAT balance_sheet (annual, 2025-12-31) — Other Payable: 162294508.00
CBAT balance_sheet (quarterly, 2025-12-31) — Other Payable: 162294508.00
CBAT balance_sheet (annual, 2025-12-31) — Other Properties: 3068591.00
CBAT balance_sheet (quarterly, 2025-12-31) — Other Properties: 3068591.00
CBAT balance_sheet (annual, 2025-12-31) — Other Receivables: 1537011.00
CBAT balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1537011.00
CBAT balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 0.00
CBAT balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 0.00
CBAT balance_sheet (annual, 2025-12-31) — Payables: 224930860.00
CBAT balance_sheet (quarterly, 2025-12-31) — Payables: 224930860.00
CBAT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 238018214.00
CBAT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 238018214.00
CBAT balance_sheet (annual, 2025-12-31) — Prepaid Assets: 3036968.00
CBAT balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3036968.00
CBAT income_statement (annual, 2025-12-31) — Pretax Income: -11136621.00
CBAT income_statement (quarterly, 2025-12-31) — Pretax Income: -7623936.00
CBAT balance_sheet (annual, 2025-12-31) — Properties: 0.00
CBAT balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CBAT cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -210177.00
CBAT cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: -70143.00
CBAT cash_flow (annual, 2025-12-31) — Purchase Of Business: -2931471.00
CBAT cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
CBAT cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
CBAT cash_flow (annual, 2025-12-31) — Purchase Of PPE: -45752180.00
CBAT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -13742220.00
CBAT balance_sheet (annual, 2025-12-31) — Raw Materials: 11897761.00
CBAT balance_sheet (quarterly, 2025-12-31) — Raw Materials: 11897761.00
CBAT balance_sheet (annual, 2025-12-31) — Receivables: 51322194.00
CBAT balance_sheet (quarterly, 2025-12-31) — Receivables: 51322194.00
CBAT balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -18271.00
CBAT balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -18271.00
CBAT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 176766718.00
CBAT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 54519790.00
CBAT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 10575797.00
CBAT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 4332374.00
CBAT cash_flow (annual, 2025-12-31) — Repayment Of Debt: -45911791.00
CBAT cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -7380138.00
CBAT cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -1500231.00
CBAT cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CBAT income_statement (annual, 2025-12-31) — Research And Development: 15801613.00
CBAT income_statement (quarterly, 2025-12-31) — Research And Development: 5302541.00
CBAT balance_sheet (annual, 2025-12-31) — Restricted Cash: 67376113.00
CBAT balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 67376113.00
CBAT balance_sheet (annual, 2025-12-31) — Retained Earnings: -133795940.00
CBAT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -133795940.00
CBAT cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
CBAT cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
CBAT cash_flow (annual, 2025-12-31) — Sale Of PPE: 149201.00
CBAT cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 674.00
CBAT income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 5076891.00
CBAT income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1897340.00
CBAT income_statement (annual, 2025-12-31) — Selling General And Administration: 21272395.00
CBAT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 7065299.00
CBAT balance_sheet (annual, 2025-12-31) — Share Issued: 88645836.00
CBAT balance_sheet (quarterly, 2025-12-31) — Share Issued: 88645836.00
CBAT cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 51177399.00
CBAT cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -45794934.00
CBAT income_statement (annual, 2025-12-31) — Special Income Charges: 210177.00
CBAT income_statement (quarterly, 2025-12-31) — Special Income Charges: 210177.00
CBAT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 76804.00
CBAT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 12992.00
CBAT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 112678073.00
CBAT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 112678073.00
CBAT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 100297555.00
CBAT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 100297555.00
CBAT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3812.20
CBAT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -25.12
CBAT income_statement (annual, 2025-12-31) — Tax Provision: -184686.00
CBAT income_statement (quarterly, 2025-12-31) — Tax Provision: -833.00
CBAT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.02
CBAT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CBAT balance_sheet (annual, 2025-12-31) — Taxes Receivable: 11273955.00
CBAT balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 11273955.00
CBAT balance_sheet (annual, 2025-12-31) — Total Assets: 426181636.00
CBAT balance_sheet (quarterly, 2025-12-31) — Total Assets: 426181636.00
CBAT balance_sheet (annual, 2025-12-31) — Total Capitalization: 116796701.00
CBAT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 116796701.00
CBAT balance_sheet (annual, 2025-12-31) — Total Debt: 37737123.00
CBAT balance_sheet (quarterly, 2025-12-31) — Total Debt: 37737123.00
CBAT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 109479591.00
CBAT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 109479591.00
CBAT income_statement (annual, 2025-12-31) — Total Expenses: 213840726.00
CBAT income_statement (quarterly, 2025-12-31) — Total Expenses: 67027664.00
CBAT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 316702045.00
CBAT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 316702045.00
CBAT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 245542925.00
CBAT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 245542925.00
CBAT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 16854037.00
CBAT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 16854037.00
CBAT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -18441243.00
CBAT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -8014975.00
CBAT income_statement (annual, 2025-12-31) — Total Other Finance Cost: 673344.00
CBAT income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 335393.00
CBAT balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1318816.00
CBAT balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1318816.00
CBAT income_statement (annual, 2025-12-31) — Total Unusual Items: -229877.00
CBAT income_statement (quarterly, 2025-12-31) — Total Unusual Items: -229877.00
CBAT income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -229877.00
CBAT income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -229877.00
CBAT balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 0.00
CBAT balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 0.00
CBAT balance_sheet (annual, 2025-12-31) — Treasury Stock: 0.00
CBAT balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 0.00
CBAT balance_sheet (annual, 2025-12-31) — Work In Process: 12055586.00
CBAT balance_sheet (quarterly, 2025-12-31) — Work In Process: 12055586.00
CBAT balance_sheet (annual, 2025-12-31) — Working Capital: -119209297.00
CBAT balance_sheet (quarterly, 2025-12-31) — Working Capital: -119209297.00
CBAT income_statement (annual, 2025-12-31) — Write Off: -210177.00
CBAT income_statement (quarterly, 2026-03-31) — +Operating Expense: 10728253.00
CBAT income_statement (quarterly, 2026-03-31) — +Total Revenue: 69617992.00
CBAT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 86325946.00
CBAT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 33237553.00
CBAT balance_sheet (quarterly, 2026-03-31) — Accrued Interest Receivable: 172163.00
CBAT balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -71915822.00
CBAT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 248500619.00
CBAT balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1127894.00
CBAT cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 2592622.00
CBAT balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 17406695.00
CBAT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 89247119.00
CBAT income_statement (quarterly, 2026-03-31) — Basic EPS: -0.10
CBAT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 75677262.00
CBAT balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 90526337.00
CBAT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -11784371.00
CBAT balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 5629832.00
CBAT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 88646.00
CBAT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 9338921.00
CBAT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9338921.00
CBAT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 11314018.00
CBAT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -11784371.00
CBAT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 22284680.00
CBAT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 47272981.00
CBAT cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 11807100.00
CBAT cash_flow (quarterly, 2026-03-31) — Change In Inventory: -26753382.00
CBAT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -145066.00
CBAT cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 1992.00
CBAT cash_flow (quarterly, 2026-03-31) — Change In Payable: 47272981.00
CBAT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 59080081.00
CBAT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -1043933.00
CBAT cash_flow (quarterly, 2026-03-31) — Change In Receivables: -7550444.00
CBAT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 23589248.00
CBAT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -7550444.00
CBAT cash_flow (quarterly, 2026-03-31) — Changes In Cash: 21814327.00
CBAT balance_sheet (quarterly, 2026-03-31) — Common Stock: 88646.00
CBAT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 105160959.00
CBAT balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 29689789.00
CBAT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 68578124.00
CBAT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 14508609.00
CBAT balance_sheet (quarterly, 2026-03-31) — Current Assets: 238425776.00
CBAT balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3303565.00
CBAT balance_sheet (quarterly, 2026-03-31) — Current Debt: 37724413.00
CBAT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 41027978.00
CBAT balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 35126888.00
CBAT balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 35126888.00
CBAT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 368202860.00
CBAT balance_sheet (quarterly, 2026-03-31) — Current Provisions: 482978.00
CBAT cash_flow (quarterly, 2026-03-31) — Depreciation: 3680954.00
CBAT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3680954.00
CBAT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3680954.00
CBAT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 89247119.00
CBAT income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.10
CBAT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -9287372.00
CBAT balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 1290232.00
CBAT income_statement (quarterly, 2026-03-31) — EBIT: -9688385.00
CBAT income_statement (quarterly, 2026-03-31) — EBITDA: -6007431.00
CBAT income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 0.00
CBAT cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 0.00
CBAT cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 1105254.00
CBAT cash_flow (quarterly, 2026-03-31) — End Cash Position: 98596843.00
CBAT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 11314018.00
CBAT balance_sheet (quarterly, 2026-03-31) — Finished Goods: 36898963.00
CBAT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 10500309.00
CBAT cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 1128941.00
CBAT cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 205945.00
CBAT income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -906255.00
CBAT balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -8300352.00
CBAT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 4510224.00
CBAT balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 12474244.00
CBAT balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 34365447.00
CBAT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 292747082.00
CBAT income_statement (quarterly, 2026-03-31) — Gross Profit: 1039868.00
CBAT balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 416535.00
CBAT cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
CBAT balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 7427.00
CBAT cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 252420.00
CBAT balance_sheet (quarterly, 2026-03-31) — Interest Payable: 83242.00
CBAT balance_sheet (quarterly, 2026-03-31) — Inventory: 75673735.00
CBAT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 150537732.00
CBAT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -11784371.00
CBAT balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 17406695.00
CBAT balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 19274264.00
CBAT cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 23251835.00
CBAT balance_sheet (quarterly, 2026-03-31) — Leases: 10092972.00
CBAT balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 37386698.00
CBAT balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 2326267.00
CBAT balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7652360.00
CBAT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 9978627.00
CBAT cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 23251835.00
CBAT cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -11937817.00
CBAT balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 1867569.00
CBAT balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 413301.00
CBAT balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 159517857.00
CBAT balance_sheet (quarterly, 2026-03-31) — Minority Interest: -2952187.00
CBAT income_statement (quarterly, 2026-03-31) — Minority Interests: -325082.00
CBAT balance_sheet (quarterly, 2026-03-31) — Net Debt: 36037852.00
CBAT income_statement (quarterly, 2026-03-31) — Net Income: -9287372.00
CBAT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -9287372.00
CBAT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -8962290.00
CBAT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -9287372.00
CBAT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -9287372.00
CBAT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -8962290.00
CBAT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -8962290.00
CBAT income_statement (quarterly, 2026-03-31) — Net Interest Income: -416095.00
CBAT cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 11314018.00
CBAT cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 11314018.00
CBAT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -416095.00
CBAT balance_sheet (quarterly, 2026-03-31) — Net PPE: 220831260.00
CBAT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -11784371.00
CBAT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 92686715.00
CBAT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 10201984.00
CBAT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 10201984.00
CBAT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -5088978.00
CBAT income_statement (quarterly, 2026-03-31) — Normalized Income: -8736300.20
CBAT balance_sheet (quarterly, 2026-03-31) — Notes Receivable: 13261599.00
CBAT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 22284680.00
CBAT cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1334886.00
CBAT income_statement (quarterly, 2026-03-31) — Operating Income: -9688385.00
CBAT income_statement (quarterly, 2026-03-31) — Operating Revenue: 69617992.00